Nutex Health NUTX
$162.64 +$0.54 (+0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $162.64 0.00%
Open$158.62
Prev close$162.10
Day range$155.04 – $165.79
Volume157.5K
Market cap$1.12B
P/E (TTM)7.0
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$217.61M-18.7% YoY
Operating profit$77.10M-40.9% YoY
Net profit$57.34M-40.8% YoY
Diluted EPS$5.71-26.4% YoY
Free cash flow$73.14M-26.3% YoY
Operating cash flow$78.35M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin47.8%
Operating margin39.0%
Net margin20.7%
Return on equity43.8%
Return on assets16.5%
Return on invested capital24.4%
Current ratio4.76
Liabilities / assets47.6%
Cash & investments$249.91M
Total debt$355.89M
Net cash (debt)-$105.98M
Free cash flow / sales31.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $217.61M | $210.75M | $216.49M | $875.26M | $151.68M |
| Total Operating Revenue | $217.61M | $210.75M | $216.49M | $875.26M | $151.68M |
| Cost of Revenue | $116.09M | $69.47M | $124.76M | $430.98M | $105.54M |
| Gross Profit | $101.53M | $141.28M | $91.73M | $444.28M | $46.14M |
| Operating Expense | $24.43M | $19.56M | $10.47M | $168.66M | $15.22M |
| Selling and Admin Expenses | $24.43M | $19.56M | $10.47M | $168.66M | $15.22M |
| -General & Admin Expense | $24.43M | $19.56M | $10.47M | $168.66M | $15.22M |
| Operating Profit | $77.10M | $121.72M | $81.27M | $275.63M | $30.92M |
| Net Non-Operating Interest Income (Expense) | -$4.86M | -$4.67M | -$4.68M | -$22.23M | -$4.98M |
| Non-Operating Interest Expense | $4.86M | $4.67M | $4.68M | $22.23M | $4.98M |
| Other Income (Expense) | $304,000.00 | $38,000.00 | -$23,000.00 | -$8.62M | -$48,000.00 |
| Other Non-Operating Income (Expenses) | $304,000.00 | $38,000.00 | -$23,000.00 | -$8.62M | -$48,000.00 |
| Pretax Profit | $72.54M | $117.09M | $76.56M | $244.78M | $25.89M |
| Tax | $15.20M | $20.77M | $13.80M | $64.42M | $9.29M |
| Net Profit | $57.34M | $96.32M | $62.76M | $180.36M | $16.61M |
| Profit from Continuing Operations | $57.34M | $96.32M | $62.76M | $180.36M | $16.61M |
| Minority Interests | $17.11M | $30.48M | $15.96M | $109.57M | $4.77M |
| Net Income to Parent Company | $40.23M | $65.84M | $46.81M | $70.79M | $11.83M |
| Net Income to Common Stockholders | $40.23M | $65.84M | $46.81M | $70.79M | $11.83M |
| Basic EPS | $5.87 | $9.58 | $6.70 | $11.13 | $1.50 |
| Diluted EPS | $5.71 | $9.38 | $6.52 | $10.48 | $1.50 |
| Special Income (Charges) | – | – | – | $0.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | – |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | $0.00 |
| -Less:Write Off | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.03B | $964.63M | $957.32M | $918.53M | $918.53M |
| Total Current Assets | $633.24M | $585.65M | $579.65M | $538.81M | $538.81M |
| Cash and Cash Equivalents & Short-Term Investments | $249.91M | $205.21M | $207.35M | $185.57M | $185.57M |
| -Cash and Cash Equivalents | $249.91M | $205.21M | $207.35M | $185.57M | $185.57M |
| Receivables | $360.84M | $356.70M | $345.90M | $325.42M | $325.42M |
| -Accounts Receivable | $360.84M | $356.70M | $345.90M | $325.42M | $325.42M |
| Inventory | $5.14M | $4.21M | $4.68M | $2.87M | $2.87M |
| Restricted Cash | $3.65M | $1.90M | $3.29M | $297,000.00 | $297,000.00 |
| Other Current Assets | $13.70M | $17.64M | $18.43M | $24.66M | $24.66M |
| Total Non-Current Assets | $399.13M | $378.98M | $377.67M | $379.71M | $379.71M |
| Net PPE | $361.22M | $340.92M | $342.18M | $343.90M | $343.90M |
| -Gross PPE | $397.78M | $376.24M | $375.78M | $375.60M | $375.60M |
| -Accumulated Depreciation | -$36.57M | -$35.32M | -$33.60M | -$31.70M | -$31.70M |
| Goodwill and Other Intangible Assets | $34.17M | $34.50M | $34.82M | $35.15M | $35.15M |
| -Goodwill | $13.92M | $13.92M | $13.92M | $13.92M | $13.92M |
| -Other Intangible Assets | $20.26M | $20.58M | $20.91M | $21.23M | $21.23M |
| Other Non-Current Assets | $3.75M | $3.56M | $668,000.00 | $662,000.00 | $662,000.00 |
| Total Liabilities | $491.47M | $457.32M | $515.27M | $495.09M | $495.09M |
| Total Current Liabilities | $132.95M | $117.22M | $184.44M | $157.91M | $157.91M |
| Payables | $22.84M | $16.70M | $67.89M | $51.72M | $51.72M |
| -Accounts Payable | $15.40M | $9.96M | $50.37M | $48.97M | $48.97M |
| -Total Tax Payable | $7.44M | $6.74M | $17.52M | $2.76M | $2.76M |
| Current Accrued Expenses | $81.30M | $77.57M | $87.41M | $74.63M | $74.63M |
| Short-Term Debt and Capital Lease Obligation | $17.26M | $18.10M | $26.41M | $23.31M | $23.31M |
| -Current Debt | $8.17M | $8.59M | $16.87M | $14.08M | $14.08M |
| -Current Capital Lease Obligation | $9.09M | $9.51M | $9.54M | $9.23M | $9.23M |
| Total Non-Current Liabilities | $358.52M | $340.10M | $330.83M | $337.18M | $337.18M |
| Long Term Debt and Capital Lease Obligation | $347.72M | $329.23M | $322.67M | $328.09M | $328.09M |
| -Long Term Debt | $34.20M | $31.11M | $24.26M | $29.17M | $29.17M |
| -Long Term Capital Lease Obligation | $313.52M | $298.13M | $298.41M | $298.91M | $298.91M |
| Non-Current Deferred Liabilities | $10.80M | $10.86M | $8.16M | $9.09M | $9.09M |
| Total Equity | $540.91M | $507.31M | $442.05M | $423.44M | $423.44M |
| Stockholders' Equity | $435.57M | $394.32M | $346.29M | $329.45M | $329.45M |
| Capital Stock | $7,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -Common Stock | $7,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| Additional Paid-In Capital | $568.87M | $567.85M | $585.67M | $615.63M | $615.63M |
| Retained Earnings | -$133.31M | -$173.54M | -$239.38M | -$286.19M | -$286.19M |
| Minority Interests | $105.34M | $113.00M | $95.76M | $93.99M | $93.99M |
| Non-Current Deferred Assets | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $78.35M | $34.20M | $75.52M | $248.13M | $70.39M |
| Net cash flow from continuing operations | $78.35M | $34.20M | $75.52M | $248.13M | $70.39M |
| Net Income from Continuing Operations | $57.34M | $96.32M | $62.76M | $180.36M | $16.61M |
| Depreciation & Depletion & Amortization | $5.62M | $5.32M | $5.49M | $20.53M | $5.19M |
| Deferred Tax | -$65,000.00 | $2.71M | -$932,000.00 | $17.08M | -$5.87M |
| Other Non-Cash Items | $17,000.00 | -$52.31M | $33,000.00 | $902,000.00 | $146,000.00 |
| Change in Working Capital | $8.04M | -$20.72M | $12.08M | -$87.74M | $56.92M |
| -Change in Receivables | -$4.14M | -$10.80M | -$20.48M | -$89.32M | $81.49M |
| -Change in Inventory | -$937,000.00 | $472,000.00 | -$1.81M | -$16,000.00 | $292,000.00 |
| -Change in Prepaid Assets | $3.75M | -$2.10M | $6.22M | -$14.61M | -$8.23M |
| -Change in Payables and Accrued Expense | $9.69M | -$8.35M | $28.13M | $15.79M | -$16.69M |
| -Change in Other Current Liabilities | -$3.58M | -$348,000.00 | -$380,000.00 | -$508,000.00 | -$344,000.00 |
| Net cash flow from investing | -$5.20M | -$2.54M | -$1.20M | -$5.24M | -$5.07M |
| Net Cash Flow from Continuing Investing Activities | -$5.20M | -$2.54M | -$1.20M | -$5.24M | -$5.07M |
| Net PPE Purchase and Sale | -$5.20M | -$2.54M | -$1.20M | -$2.53M | -$1.41M |
| Financing Cash Flow | -$26.69M | -$35.19M | -$49.55M | -$97.95M | -$45.79M |
| Net Cash Flow from Continuing Financing Activities | -$26.69M | -$35.19M | -$49.55M | -$97.95M | -$45.79M |
| Net Issuance Payments Of Debt | -$2.10M | -$3.21M | -$3.70M | -$19.44M | -$9.14M |
| Cash Dividends Paid | -$25.09M | -$13.26M | -$15.36M | -$74.28M | -$32.10M |
| Proceeds from Stock Option Exercised | $175,000.00 | – | – | $0.00 | $0.00 |
| Net Other Financing Charges | $51.01M | -$50.52M | $1.24M | $767,000.00 | $451,000.00 |
| Ending Cash Balance | $253.56M | $207.11M | $207.35M | $185.87M | $185.87M |
| Net Change in Cash | $46.45M | -$3.53M | $24.77M | $144.93M | $19.53M |
| Beginning Cash Balance | $207.11M | $207.35M | $185.87M | $40.64M | $166.05M |
| Free Cash Flow | $73.14M | $31.66M | $74.32M | $245.60M | $68.98M |
| -Change In Other Working Capital | – | – | $401,000.00 | – | – |
| Net Common Stock Issuance | – | – | -$31.73M | -$5.00M | -$5.00M |
| -Change in Other Current Assets | – | – | – | $917,000.00 | – |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Investment Purchase and Sale | – | – | – | $1.60M | – |
| Net Other Investing Changes | – | – | – | -$4.31M | -$5.26M |
No comments yet — be the first to weigh in on NUTX.
Sign in to join the discussion.